Interferon‐γ priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages

Recognition of microbial products by macrophages (Mφ) stimulates an inflammatory response and plays a critical role in directing the host immune response against infection. In the present work, we showed for the first time that synthetic oligodeoxynucleotides containing unmethylated cytosine guanine motifs (CpG) are able to stimulate, in the presence of interferon‐γ (IFN‐γ), both arginase and inducible nitric oxide synthase (iNOS) in murine Mφ. Unexpectedly, IFN‐γ, a cytokine believed to be an inhibitor of arginase activity, intervened in the activation of this enzyme. A significant increase in arginase activity was observed upon a short pre‐incubation (1 hr) with IFN‐γ and subsequent CpG stimulation. Therefore, a very interesting observation of this study was that the CpG‐mediated arginase activity is dependent on IFN‐γ priming. The increase in arginase activity as a result of stimulation with CpG plus IFN‐γwas correlated with augmented expression of the arginase II isoform. The use of pharmacological specific inhibitors revealed that arginase activity was dependent on p38 mitogen‐activated protein kinase (MAPK) and extracellular signal‐regulated protein kinase (ERK), but independent of c‐Jun N‐terminal kinase (JNK) activation. This report reveals a singular effect of the combination of CpG and IFN‐γ, one of the mayor cytokines produced in response to CpG administration in vivo.

[1]  A. Valledor,et al.  Selective Roles of MAPKs during the Macrophage Response to IFN-γ1 , 2008, The Journal of Immunology.

[2]  P. Tripathi.  Nitric oxide and immune response. , 2007, Indian journal of biochemistry & biophysics.

[3]  S. Akira,et al.  Induction of an anti-inflammatory cytokine, IL-10, in dendritic cells after toll-like receptor signaling. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[4]  Kate Schroder,et al.  Signal integration between IFNgamma and TLR signalling pathways in macrophages. , 2006, Immunobiology.

[5]  A. Krieg,et al.  Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.

[6]  A. Ding,et al.  MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA , 2006, Nature Immunology.

[7]  D. Busch,et al.  Systemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO , 2006, European journal of immunology.

[8]  Miriam V. Liscovsky,et al.  CpG oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice. , 2005, Clinical immunology.

[9]  B. Baban,et al.  Cutting Edge: CpG Oligonucleotides Induce Splenic CD19+ Dendritic Cells to Acquire Potent Indoleamine 2,3-Dioxygenase-Dependent T Cell Regulatory Functions via IFN Type 1 Signaling1 , 2005, The Journal of Immunology.

[10]  Miriam V. Liscovsky,et al.  Orally administered OVA/CpG‐ODN induces specific mucosal and systemic immune response in young and aged mice , 2005, Journal of leukocyte biology.

[11]  A. Gobert,et al.  Protective Role of Arginase in a Mouse Model of Colitis1 , 2004, The Journal of Immunology.

[12]  W. Grody,et al.  Arginases I and II: do their functions overlap? , 2004, Molecular genetics and metabolism.

[13]  K. Schroder,et al.  Interferon‐γ: an overview of signals, mechanisms and functions , 2004 .

[14]  B. Monks,et al.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.

[15]  H. Mühl,et al.  Anti-inflammatory properties of pro-inflammatory interferon-gamma. , 2003, International immunopharmacology.

[16]  R. Ferrante,et al.  Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  I. Hussain,et al.  Immunomodulatory Effects of CpG Oligodeoxynucleotides on Established Th2 Responses , 2002, Clinical and Vaccine Immunology.

[18]  Peter J. Murray,et al.  Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.

[19]  Marina A Dobrovolskaia,et al.  Toll receptors, CD14, and macrophage activation and deactivation by LPS. , 2002, Microbes and infection.

[20]  Jae-Geun Yoon,et al.  Role of Mitogen-Activated Protein Kinases in CpG DNA-Mediated IL-10 and IL-12 Production: Central Role of Extracellular Signal-Regulated Kinase in the Negative Feedback Loop of the CpG DNA-Mediated Th1 Response1 , 2002, The Journal of Immunology.

[21]  Chilakamarti V. Ramana,et al.  Stat1-dependent and -independent pathways in IFN-γ-dependent signaling , 2002 .

[22]  E. Pearce,et al.  Differential Regulation of Nitric Oxide Synthase-2 and Arginase-1 by Type 1/Type 2 Cytokines In Vivo: Granulomatous Pathology Is Shaped by the Pattern of l-Arginine Metabolism1 , 2001, The Journal of Immunology.

[23]  H. Davis,et al.  CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice. , 2001, FEMS immunology and medical microbiology.

[24]  K. Heeg,et al.  Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs1 , 2001, The Journal of Immunology.

[25]  C. Macleod,et al.  Sustained Nitric Oxide Production in Macrophages Requires the Arginine Transporter CAT2* , 2001, The Journal of Biological Chemistry.

[26]  T. Crabtree,et al.  Enhanced Murine Macrophage TNF Receptor Shedding by Cytosine-Guanine Sequences in Oligodeoxynucleotides1 , 2000, The Journal of Immunology.

[27]  B. Veyret,et al.  l-Arginine Availability Modulates Local Nitric Oxide Production and Parasite Killing in Experimental Trypanosomiasis , 2000, Infection and Immunity.

[28]  M. Klein,et al.  Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice , 1999, European journal of immunology.

[29]  D. Schwartz,et al.  Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. , 1999, Journal of immunology.

[30]  T. Gotoh,et al.  Expression of arginase II and related enzymes in the rat small intestine and kidney. , 1999, Journal of biochemistry.

[31]  T. Gotoh,et al.  Arginase II Downregulates Nitric Oxide (NO) Production and Prevents NO-mediated Apoptosis in Murine Macrophage-derived RAW 264.7 Cells , 1999, The Journal of cell biology.

[32]  S. Morris,et al.  Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. , 1998, American journal of physiology. Endocrinology and metabolism.

[33]  A. Krieg,et al.  Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. , 1998, Journal of immunology.

[34]  D. Hume,et al.  IFN-gamma primes macrophage responses to bacterial DNA. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[35]  D. Berg,et al.  Interleukin-10 functions in vitro and in vivo to inhibit bacterial DNA-induced secretion of interleukin-12. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[36]  M. Takiguchi,et al.  Coinduction of Nitric-oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.

[37]  J. Cobb,et al.  Nitric oxide and septic shock. , 1996, JAMA.

[38]  L. Ignarro,et al.  Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. , 1995, Biochemical and biophysical research communications.

[39]  M. Modolell,et al.  Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.

[40]  M. Modolell,et al.  Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. , 1995, Biochemical and biophysical research communications.

[41]  M. Modolell,et al.  Determination of arginase activity in macrophages: a micromethod. , 1994, Journal of immunological methods.

[42]  G. Stark,et al.  The control of interferon‐inducible gene expression , 1991, FEBS letters.

[43]  M. Caldwell,et al.  Temporal expression of different pathways of 1-arginine metabolism in healing wounds. , 1990, Journal of immunology.

[44]  A. Ding,et al.  MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. , 2006, Nature immunology.

[45]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[46]  A. Krieg,et al.  CpG motifs in bacterial DNA and their immune effects. , 2002, Annual review of immunology.

[47]  G. Stark,et al.  Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. , 2002, Trends in immunology.

[48]  J. Liao,et al.  Arginase modulates nitric oxide production in activated macrophages. , 1998, American journal of physiology. Heart and circulatory physiology.

[49]  M. Idei,et al.  Arginine supply for nitric oxide synthesis and arginase is mainly exogenous in elicited murine and rat macrophages. , 1994, Life sciences.